Kiora Pharmaceuticals (KPRX) P/E Ratio
P/E Ratio as of Jun 16, 2025: -0.92
Average-0.9562
Median-0.9400
Minimum-1.19
Maximum-0.8700
-0.92
Past Month+0.04 (4.17%)
The P/E ratio for Kiora Pharmaceuticals (KPRX) is -0.92 as of Jun 16, 2025. This represents a decrease of -46.51% compared to its 12-month average P/E ratio of -1.72. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Kiora Pharmaceuticals P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Kiora Pharmaceuticals’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Kiora Pharmaceuticals to industry peers.
Kiora Pharmaceuticals P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Kiora Pharmaceuticals’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Kiora Pharmaceuticals to industry peers.
Kiora Pharmaceuticals (KPRX) P/E Ratio Insights
See Kiora Pharmaceuticals’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Kiora Pharmaceuticals (KPRX)
Order type
Buy in
Order amount
Est. shares
0 shares
Kiora Pharmaceuticals (KPRX) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $2.85 | -0.87 |
| May 1, 2025 | $3.2841 | 4.65 |
| Apr 1, 2025 | $2.93 | 4.14 |
| Mar 3, 2025 | $3.07 | -5.74 |
| Feb 3, 2025 | $3.83 | -7.15 |
| Jan 2, 2025 | $3.58 | -6.69 |
Kiora Pharmaceuticals (KPRX) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -0.92 | -85.06% |
| 2024 | -6.16 | +4,638.46% |
| 2023 | -0.13 | +62.50% |
| 2022 | -0.08 | -92.23% |
| 2021 | -1.03 | -63.08% |
| 2020 | -2.79 | — |
FAQs About Kiora Pharmaceuticals (KPRX) P/E ratio
The latest P/E ratio of Kiora Pharmaceuticals (KPRX) is -0.92, as of Jun 16, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Kiora Pharmaceuticals’s last 12-month average P/E ratio is -1.72, compared to its current P/E ratio of -0.92. This reflects a decrease of -46.51%.
Kiora Pharmaceuticals’s current P/E ratio of -0.92 is lower than its last 12-month average P/E of -1.72. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Kiora Pharmaceuticals’s average P/E ratio over the last 3 years is -0.7. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Kiora Pharmaceuticals’s average P/E ratio over the last 5 years is -1.07. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.